معرفی
Pawel Licznerski is an Associate Research Scientist in the Department of Medicine (Endocrinology) at Yale University's School of Medicine. He holds a PhD in Neuroscience from the University of Heidelberg (2004) and an MSc in Biotechnology from the Intercollegiate Faculty of Biotechnology (2000). His research focuses on mitochondrial biology, neurodegeneration, synaptic plasticity, and the molecular mechanisms underlying neurological disorders such as Fragile X Syndrome and depression.
Key research interests include ATP synthase function, Bcl-xL signaling pathways, and the role of mitochondrial dysfunction in disease. He collaborates extensively with researchers like Elizabeth Jonas, Kambiz Alavian, and Gerard Sanacora, contributing to groundbreaking studies on mitochondrial proton leak in Fragile X Syndrome and astroglial modulation of anhedonia-like behaviors in depression models.
His publications span high-impact journals such as Cell, Nature Cell Biology, and Proceedings of the National Academy of Sciences. Recent work highlights include elucidating mitochondrial defects in Fragile X Syndrome and discovering astroglial roles in mood disorders. His research bridges basic science and translational medicine, targeting neurodegenerative and psychiatric conditions.
Licznerski’s work integrates cellular metabolism, synaptic biology, and stress signaling, with a focus on developing therapeutic strategies for neurological diseases. He maintains an active lab at Yale, though specific lab affiliations are not detailed in the provided texts.
